Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An announcement from Lexeo Therapeutics, Inc. (LXEO) is now available.
On March 11, 2024, Lexeo Therapeutics, Inc. secured a deal to privately place over 6 million shares at $15.13 each, aiming to raise approximately $95 million before fees. The proceeds are earmarked for general corporate purposes and working capital. The agreement includes registration rights, ensuring the resale of shares under specific conditions, and involves board-affiliated entities purchasing $6 million worth of shares. This strategic move is accompanied by a press release updating the company’s financial status, with the transaction hinging on customary closing conditions and relevant securities regulations.
For an in-depth examination of LXEO stock, go to TipRanks’ Stock Analysis page.
